Mindray Transforms Spot Check Patient Monitoring with New VS Series Vital Signs Monitors
SHENZHEN, China, Jan. 26, 2021 /PRNewswire/ Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, today launched its new VS 9 and VS 8 Vital Signs Monitors, which are now available in Europe, Australia and other selected regions. From inpatient admissions to spot checks, Mindray VS Series unlocks the full potential of routine observations, empowering medical staff to deliver patient-centric care.
In order to monitor patient status precisely and timely, nurses need to record and file vital signs in detail for each patient, which increases both the workload and the risk of error caused by manual transcription. Mindray VS Series addresses these challenges with a true-to-life workstation that transforms spot check patient monitoring.